Global Adult Vaccine Industry is projected to grow with a CAGR of 6% from 2021-2027

According to Renub Research report titled, “Adult Vaccine Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Adult Vaccine Market is estimated to reach USD 18.8 Billion by 2021. Over the years, vaccine-preventable diseases have been killing thousands of adults each year worldwide. Vaccines, surprisingly, are used to prevent infections and boost the body’s immunity. Hence, adult vaccination has become one of the most cost-effective public health interventions accessible today. Moreover, it is also a biological preparation that comprises an agent that looks like a disease-causing germ created from weakened and destroyed microorganisms.

Global Adult Vaccine Market to Reach US$ 26.7 Billion by 2027

Global Adult Vaccine Industry Is Projected to Grow with A CAGR of 6% From 2021-2027:

Some of the major drivers for the global adult vaccines market are increased illness prevalence and novel vaccination technologies. Furthermore, increased research in the field of vaccine technology and increasing government backing are all contributing to the global adult vaccines market’s growth. Several government agencies are funding and granting research on customized vaccinations to improve their efficacy and disease-prevention potential.

In addition, some government organizations are putting in place particular requirements for their safe practices. Increased R&D investment by pharmaceutical and biopharmaceutical companies and widespread R&D pipelines are expected to help move the worldwide adult vaccines market forward.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Disease wise – Adult Vaccines Market & Numbers of Adults Vaccinated:

In our report, Coronavirus (COVID-19), Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, TdaP, and Varicella are the diseases included. Furthermore, due to the growing negative worries about prevalent infectious diseases, which are the leading causes of mortality and morbidity worldwide, the number of immunizations for various diseases is at an all-time high.

Further, the worldwide number of adult vaccines vertical has seen significant expansion due to the continual increase in demand for immunization against severe diseases such as cholera, typhoid, hepatitis, measles, chickenpox, and many others. On the other hand, several molecular entities are through substantial research and development stages and are aimed at immunizing against deadly diseases.

Key Players in the Global Adult Vaccine Industry:

The significant companies studied in the global adult vaccine market include GlaxoSmithKline, plc, Merck & Co.’s, Sanofi Pasteur’s, Pfizer, Inc.’s, and Thoracic Aortic Aneurysm (TAA) CSL Limited’s. As per our analysis, the key players are focusing on business expansion to increase their revenue share by implementing mergers and acquisitions and new product development strategies. For instance, GlaxoSmithKline plc announced in 2021 that they had submitted a (BLA) Biologics License Application to the US Food and Drug Administration for their investigational vaccine PRIORIX, requesting authorization to use it against measles, mumps, and rubella (MMR) in the United States. The vaccine was first registered in Germany and is now approved in more than 100 countries worldwide.

COVID-19’s Impact on the Global Adult Vaccine Market:

The COVID-19 pandemic had a diverse impact on the global adult vaccine industry. Vaccination rates for some vaccines have decreased. On the other hand, vaccination rates for a few vaccines, such as flu vaccines, have increased. The introduction of COVID-19 vaccines has significantly impacted the vaccine industry’s overall growth. Furthermore, we aim to see the global adult vaccines market to quantify the health, economic, and social benefits of vaccines and immunization programs to individuals and society.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Market Summary:

  • Disease Wise: We have analysed the market for Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel and Miscellaneous, Varicella)
  • Numbers of Vaccinated Adults: We have covered the numbers of vaccinated adults for Influenza, Meningococcal, Cervical Cancer (HPV), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Zoster (Shingles), Hepatitis, TdaP, Varicella.
  • Company Analysis: The key players covered in our report are GlaxoSmithKline, plc., Merck & Co., Sanofi Pasteur’s, Pfizer, Inc., Thoracic Aortic Aneurysm (TAA) CSL Limited.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

United States Anesthesia Drugs Market will grow with a CAGR of 4% from 2021-2027

As per the latest report by Renub Research titled “United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” United States Anesthesia Drugs Market Size was US$ 4.9 Billion by 2027. In the United States, anesthesia drug is one of the milestones in the pharmaceutical industry, which benefits patients with painless treatment and impossible to perform surgery. The US is home to bigwigs in the pharmaceutical sector to increase their stakes in the United States market. Anesthesia meant the condition of holding sensation blocked or temporarily taken away. This authorizes the patient to undergo surgery and other procedures without distress and pain they would otherwise experience. Anesthesia drugs are used while performing surgical procedures to control pain, heart rate, blood pressure, breathing, rhythm, and blood flow.

Top Impacting Factors:

Notwithstanding, the United States anesthesia drug market is driven by the rising number of surgeries, the growing aging population with increasing chronic conditions, and advancements in anesthesia technologies. As per the statistics provided by the (ASPS) American Society of Plastic Surgeons, in 2019, nearly 16.3 Million cosmetic minimally-invasive procedures and 1.8 Million cosmetic surgical were performed in the United States.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=united-states-anesthesia-drugs-market-and-forecast-31-p.php

Furthermore, the demand for various anesthetics goes hand-in-hand with the performed surgical procedures. The application of anesthetics in general surgeries is anticipated to contribute significantly to the market’s growth in the United States. Further, new anesthesia drugs are being developed, which is predicted to propel market growth. For instance, in 2020, Medova and the New York School of Regional Anesthesia (NYSORA) entered a partnership to introduce SAFIRA (SAFer Injection for Regional Anesthesia) in the United States.

COVID-19 Impact on Anesthesia Drugs Industry:

In the United States, the demand for anesthesia drugs seen a slight drop in 2020 due to the emergence of the pandemic situation, cancelled surgeries or leading to delayed. With the emergence of COVID-19, the United States faced extreme shortages of vital anesthesia drugs, mainly canceled surgeries, dexmedetomidine, midazolam, Propofol, and neuromuscular blocking agents. Most of the surgeries were delayed, and only acute surgical emergencies were managed. Thus, the COVID-19 has an unfavorable impact on the United States anesthesia drugs industry. As a result, numerous players are ramping up their production of anesthesia drugs. For instance, in 2020, Hikma Pharmaceutical introduced a new product, “Propofol Injectable Emulsion,” in the United States.

General Inhalation Anesthesia is the Leading Segments in the United States Anesthesia Market

Based on type, the United States anesthesia drugs market includes the General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market, and Local Anesthesia Drugs Market. General Inhalation Anesthesia Drugs Market holds a considerable market share; the inhaled anesthetics include desflurane, isoflurane, sevoflurane, and others that enhance inhibit excitatory synaptic activity and inhibitory postsynaptic channel activity. General intravenous anesthesia drugs are less costly and do not need expensive machines for administration. Moreover, intravenous anesthesia drugs result in undersized cardiovascular depression and better postoperative analgesia.

Besides, general intravenous anesthesia is the leading segment in the United States Anesthesia Market. Fospropofol Disodium, Propofol, Benzodiazepines Class, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, and Fentanyl are generally utilized general intravenous anesthesia in the United States. Propofol drug is one of the most frequently used general anesthetics in surgeries among these anesthesia drugs. It is utilized as a sedative for critical care (including COVID-19) in the ICU. It is used to maintain procedural sedation, initiate general anesthesia, etc. In  2020, the United States (FDA) Food & Drug Administration approved the usage of Fresenius Propoven 2% emulsion to maintain sedation in COVID-19 patients (16 years and above) requiring mechanical ventilation.

Competitive Landascape

The United States anesthesia drugs market is highly competitive and consists of several major players. Most of the anesthesia drugs trade is generic and are available at a low cost. The key players include Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-anesthesia-drugs-market-and-forecast-31-p.php

Market Summary:

  • Types – Renub Research Report covers United States Anesthesia Drugs Market by type in the 3 viewpoints (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market)
  • United States Anesthesia Drugs Market – This has been further break-up in 8 segments: Propofol, Benzodiazepines Class (Diazepam and Midazolam), Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, Fentanyl
  • United States General Inhalation Anesthesia Drugs Market – This has been further break-up in 4 segments: Sevoflurane, Desflurane,   Isoflurane, Others
  • United States Local Anesthesia Drugs Market – This has been further break-up in 7 segments: Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other Local Anesthetics
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Oncology Precision Medicine Market is expected to grow at a CAGR of 11.6% during 2021-2027

As per the latest report by Renub Research titled “Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients’ tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient’s cancer that best matches, or targets, the culprit mutations in the tumor DNA.

Likewise, some of the more common cancers where precision medicine is being used to help with treatment decisions include Lung Cancer, Stomach Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Colorectal Cancer, Breast Cancer, r, cervical cancer, Kidney Cancer, and Bladder Cancer. Notwithstanding, the existing oncology precision medicine market is preferred by multiple factors, including several government initiatives, rising cancer incidences, and death rates, coupled with the general population’s growing awareness about molecular-level diagnosis and treatment. Besides, the increasing number of advancements in molecular diagnostics, increasing FDA approvals for such precision medicine-based oncology drugs, enhancing focus on research and development activities by crucial healthcare companies also led to market expansion. Furthermore, the development of newer therapeutic approaches, including gene therapy for cancer treatment and a rising number of patients undergoing predictive diagnosis, will propel the market growth.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=oncology-precision-medicine-market-p.php

COVID-19 Impact on Oncology Precision Market

COVID-19 has impacted the oncology precision medicine market. This impact was mainly due to disturbance of the supply chain and lockdowns imposed in many countries. Nevertheless, as the lockdowns were raised and supply was restored, the market has recovered quickly. As precision medicine deals majorly with fatal disorders like cancer involving life-saving drugs, the COVID-19 pandemic is poised to impact the market during the assessment period. Majorly for individuals living with cancer, the pandemic posed a unique set of challenges. The pandemic has certainly hindered surgeries and testing on biopsy tissue and has also impacted cancer patients’ ability to receive provider-administered drugs. Thus, the volume of oncology precision drugs and services declined notably in 2020.

Hospital end-users accounted for the largest share of the global oncology precision medicine market

On the basis of end-user, the global oncology precision medicine market is categorized into Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others. The hospital’s segment accounted for the most significant market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of cancer diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine. As per our research findings, Worldwide oncology precision medicine market was USD 33.40 Billion in 2021

North Americans raise oncology precision medicine production:

Geographically, North America is leading the oncology precision medicine market. The number of cancer patients in North America is growing notably. According to the (ACS) American Cancer Society, cancer is the leading reason of death in Canada and the second leading cause of death in the U.S. In U.S, about 1.8 million new cancer cases were diagnosed in 2020. High awareness in the region regarding precision medicine and increasing demand for personalized cancer treatment will drive the industry revenue in the region. The level of medical procedures, such as radiation, chemotherapy, and immunotherapy required, will depend upon the stage and type of cancer. Precision medicines play an essential role in helping physicians determine a suitable treatment plan based on the current genetic mutations of the patient.

Similarly, oncology precision medicine treatments have gained momentum among clients in the Asia-Pacific region in the past few years. They utilize advanced technologies and innovative methods to create personalized medicines that cater to patients’ medical needs. The global precision medicine market players are Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/oncology-precision-medicine-market-p.php

Market Summary:

  • Product Type – We have covered Global Oncology Precision Medicine Market breakup by 2 viewpoints by- product type (Diagnostics and Therapeutics)
  • Indication – Renub Research Report covers by Indication in the 11 viewpoints (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer)
  • End Users – Our Report has covered Global Oncology Precision Medicine Market breakup by 4 End Users (Hospitals, Diagnostic Centers, Research & Academic Institutes and Others)
  • Region – This Report covers by Region in the 5 viewpoints (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Pediatric Vaccine Industry to register a CAGR of 4.4% during the forecast period of 2021-2027

As per the latest report by Renub Research titled “Pediatric Vaccines Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” Pediatric Vaccines Market Size was US$ 47.8 Billion by 2021. The vaccines administered to stop children from contracting several infectious diseases and non-infectious are pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause disease. Additionally, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus.

Besides, pediatric vaccines are distributed to a child in its pediatric age, from 0 –18 years. Vaccines are commonly given to prevent children from diseases transferred through seasonal variations, infections, and even though unhygienic areas. Depending upon the disorder, the vaccines are administered at regular intervals. World Health Organization (WHO) has designed a standard immunization program to have desired time interval between vaccines doses.

Pediatric Vaccine Growth Factors

Globally, the growing prevalence of chronic disorders such as diphtheria, tuberculosis, and pneumonia in the age of 15 years and downward will contribute to the development of the pediatric vaccines industry. According to WHO, globally around 5 billion severe illnesses and 0.5 billion deaths yearly. As immunization plays a vital role in modern medicine, several international programs for children may vary based on the disease. Nevertheless, these programs are primarily driving the demand in the pediatric vaccines market. Further, the global pediatric vaccines market is driven by factors such as the global initiative undertaken by key players to develop innovative vaccines and increase government support.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=pediatric-vaccines-market-p.php

The Combos Vaccine Segment is to Grow at a Significant Rate:

Based on Vaccine Types, the Pediatric Vaccine industry includes Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19). Infections are always a leading cause of mortality and morbidity in children under 5 years of age, most of which can be stopped by vaccination. However, too many vaccines are to be administered, increasing the cost of immunization and visits to the pediatrician. Combination vaccines can answer these problems until developing a single vaccine containing all the possible antigens.

Additionally, combination vaccines such as the 5-in-1 and the MMR have been developed to help reduce the number of injections needed. Even so, children and babies often receive several vaccines at once. For example, a 2-month-old baby will simultaneously obtain the 5-in-1, PCV, Rotavirus, and MenB vaccines. Moreover, as per our Report statistics, the number of infants vaccinated from Combination Vaccines across the world was 163.52 Million in 2021, and it increased appreciably to 339.04 Million by 2027.

COVID-19 Impact on Global Pediatric Vaccines Market:

The COVID-19 has upended the lives of children and their families. Therefore, amidst the pandemic, the global market for Pediatric vaccines dropped in 2020 as most healthcare personnel were busy in COVID-19 management. The pandemic naturally affected the routine immunization programs and campaigns conducted globally in developing and developed countries. The UNICEF and World Health Organization (WHO) warned of an alarming drop in the number of children receiving life-saving vaccines worldwide. This is due to troubles in the delivery and uptake of immunization services caused by the COVID-19 pandemic.

Regardless, Influenza vaccination rates have gone up considerably during the pandemic due to push from health experts/health departments and the extension of different government programs that provide free vaccination against the flu. Also, growing awareness among the public about the higher risk of getting infected with COVID-19 if the flu weakens the immune system is another factor contributing to the uptake of flu vaccines.

Key Players:

The pediatric vaccines industry consists of several major players, including GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited. The companies enforce specific strategic initiatives like new product launches, mergers, acquisitions, and partnerships, which help them strengthen their market position.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/pediatric-vaccines-market-p.php

Market Summary:

  • Vaccine Types – We have covered Global Pediatric Vaccines Market & Numbers of Population breakup by 2 viewpoints by Vaccine Type (Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19))
  • Regions – We have covered all the 5 Regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa in this report
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Dialysis Market Size registered a CAGR of 5.7% from 2021 to 2027

As per the latest report by Renub Research titled “Global Dialysis Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” Global Dialysis Market Size was USD 92.5 Billion in 2021. Worldwide, dialysis is an essential and life-saving treatment for chronic renal failure (CRF), kidney diseases, end-stage renal disease (ESRD). Dialysis is a treatment that purifies blood using a machine. It utilizes special equipment to remove excess water and waste products from the blood. In this procedure, the blood is filtered, excess toxins and fluid are removed, and electrolyte balance is restored. Dialysis is carried out in two ways: peritoneal and hemodialysis dialysis. Both perform the usual filtering of waste kidney functions and excess fluid from the blood.

Key Factors Driving the Growth of the Dialysis Industry:

Dialysis market growth is driven by the increasing diabetic population, higher prevalence among ageing population, and rising cases of ESRD are anticipated to drive the market. Further, an increase in the advancement of home-based services and the number of treatment centers are the aspects attributing toward the dominance of the services segment. Moreover, improved reimbursement policies for renal treatment by private and public institutions are encouraging the expansion of the market at a remarkable rate. For instance, in 2020, according to the End-Stage Renal Disease (ESRD) PPS final rule, the Centers for Medicare & Medicaid Services (CMS) to pay around US$ 10.3 billion in Medicare reimbursements to about 7,000 ESRD providers for the costs of delivering renal hemodialysis services.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-dialysis-market-p.php

How Coronavirus Affected the Dialysis Industry

Besides, the COVID-19 pandemic had a moderate impact on the market. COVID-19 is majorly a respiratory disease, but it has also been shown to impact kidneys, damaging the organ to cause acute renal infection (AKI). The pandemic also disrupted the supply chain operations and affected the availability of hemodialysis, consumables for peritoneal dialysis, and essential medicines, leading to a drop in dialysis procedures performed in several dialysis centers. Due to such adverse scenarios, the overall impact of the COVID-19 pandemic on the market is to be substantial.

Hemodialysis to Account for Maximum Share

Based on type, the dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is a significant contributor to the dialysis market growth. Hemodialysis helps balance minerals such as sodium, calcium, and potassium that aids in decreasing blood pressure. Routine hemodialysis is conducted in a hospital, dialysis outpatient facility, or a dedicated stand-alone clinic that surges the market demand. Also, the growing prevalence of chronic kidney diseases across the globe will boost the acceptance rate of hemodialysis among the patient population base. Hemodialysis is classified into short daily, conventional hemodialysis, hemodialysis, and nocturnal hemodialysis.

In terms of end-users, the dialysis market is segmented into in-center and home dialysis. Dialysis treatments centers accounted for the significant market, attributable to the favorable reimbursement provided by renal facilities. Most patients prefer to obtain dialysis treatments through services delivered by dialysis centers making them the most significant contributor to the global dialysis market. Regardless, a rise in awareness and surge in demand for home healthcare among dialysis patients is predicted to make home dialysis the fastest-growing segment during the forecast period. Home dialysis offers several benefits, including reducing travel expenses, improved quality of life, flexibility, and accessible patient mobility.

Rising Dialysis Cases in the North American Region will Fuel the Industry’s Progression:

Amongst regions worldwide, North America is projected to lead the dialysis market owing to the higher usage of dialysis therapy to treat several end-stage renal diseases and chronic kidney diseases. The high prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the pivotal factors estimated to boost the expansion of the market during the forecast period. Further, the North American region is projected to see growth attributable to the growing incidence of coronavirus infections and succeeding renal failures. Likewise, the Asia-Pacific region is anticipated to witness the growth in dialysis market during the coming year, which is attributed to a low rate of organ transplantation, surge in the incidence rate of kidney failure, and advancement in healthcare expenditure.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-dialysis-market-p.php

Competitive Landscape

The prominent players operating in the dialysis market include Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc. These variant market participants are undertaking various progressive strategies to capture a higher revenue share in this dialysis market. Several development strategies enforced by foremost market players have helped them maintain a strong position in the industry.

Market Summary:

  • Type – We have covered Global Dialysis Market breakup by 2 viewpoints by Type (Hemodialysis, Peritoneal dialysis)
  • Product & Services – Renub Research Report covers by Product & Services in the 4 viewpoints (Services, Equipment, Consumables, and Drugs)
  • End-Users – Our Report has covered Global Dialysis Market breakup by end-users 2 viewpoints (In-center dialysis, Home dialysis)
  • Regions – Global Dialysis Market has covered by Region 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Spinal Fusion Market to Reach USD 9.93 Billion by 2027

According to Renub Research, report titled “Spinal Fusion Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis” the Global Spinal Fusion Device Market was USD 7.48 Billion in 2021. Surgical procedures and implant-device (cage) technologies for spinal fusion have evolved dramatically over 40 years. Furthermore, design and materials have developed with a single purpose in mind: to create implants that satisfy all three critical concerns of the procedure: stability, lordosis restoration, and osteointegration. As a result, spinal fusion remains the gold standard for treating spinal instability, deformity, and degenerative illness. Spinal fusion, also known as spinal arthrodesis, is a surgical operation that involves joining two or more vertebral bodies in the spine.

Worldwide Spinal Fusion Device Market is anticipated to grow at a CAGR of 4.8% from 2021-2027

The global spinal fusion devices market is predicted to increase moderately, opening up a slew of new prospects. The increase in the elderly population and the rise in the frequency of spinal illnesses are driving the market’s expansion. In addition, the market is expected to rise as the number of indications for spinal fusion surgery grows. For example, spinal fusion was once reserved for scoliosis and spinal tuberculosis, but it is now used to treat 14 other disorders. It’s also worth noting that technological advancements are helping to drive the business forward.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=global-spinal-fusion-market-procedure-volume-and-forecast-495-p.php

The Thoracolumbar Devices Segment Is the Market Leader:

By product type, Cervical Device, Thoracolumbar Device, Interbody Device, and Biologics are covered in our report. According to our research, the thoracolumbar devices category dominates the spinal fusion device market. The segment is being driven even further by the rising incidence of spinal problems such as spinal stenosis, severe kyphosis, and vertebral fracture. In most of these cases, surgery is the only choice for treatment. Furthermore, thoracolumbar fractures can be the most common reason for surgical intervention. Road accidents or bone insufficiency are the two most common causes of fractures. Bone insufficiency is caused by underlying conditions such as osteoporosis and tumors, weakening the bone and leading to fractures.

The Degenerative Disc Segment Is Rapidly Growing:

In our report, we have studied Degenerative Disc Disease, Complex Deformity, and Traumas & Fractures as disease indicator types. Over the projection period, the complex deformity segment would dominate the market for spinal fusion devices. On the other hand, expanding reasons for lower back and neck discomfort in adults and an increase in the older population are the main factors driving the degenerative disc segment. In addition, the evolution of sports and daily activities is predicted to contribute to category expansion. As a result, according to our analysis, the degenerative disc section of the spinal fusion market is expected to multiply.

End-user Perspectives on the Spinal Fusion Device Industry:

Our report covers Ambulatory Surgical, Specialty Clinics, and Hospitals. For decades, one of the elements propelling the hospital segment has been the increasing number of spine procedures conducted in hospitals. Furthermore, in developing countries such as India, significant government measures to enhance healthcare infrastructure and develop the middle-class population result in augmented demand for excellent healthcare services offered by hospitals, assisting segment expansion. As a result, according to our analysis, hospitals are expected to dominate the market for spinal fusion devices by the end-user.

The Market for Spinal Fusion Devices in Different Regions:

Our analysis divides the world into five regions: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The growing geriatric population in North America and the increased incidence of sports injuries and fatal accidents are among the primary drivers driving demand for spinal fusion devices in the North American region. Furthermore, the region’s well-developed healthcare infrastructure will likely drive market expansion for spinal fusion devices. Furthermore, essential player advancements are projected to enhance market growth by creating substantial untapped opportunities.

Insights for Key Players:

Alphatec Holdings, Inc., B. Braun Group, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, ORTHOFIX MEDICAL INC, Stryker, and Zimmer Biomet Holdings are some of the leading companies in the spinal fusion device market. With numerous large and small industry participants, the market for spinal fusion devices is very competitive. To get a more extensive market share, these companies pursue strategies such as geographical expansion, new product releases, partnerships, and collaborations.

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/global-spinal-fusion-market-procedure-volume-and-forecast-495-p.php

COVID-19’s Impact on the Global Spinal Fusion Device Market:

The COVID-19 epidemic has had an impact on just about every business. The market for spinal fusion devices, like other healthcare industries, has been completely impacted. The COVID-19 epidemic situation in several nations has created obstacles for spinal fusion devices used in hospitals and clinics to provide orthopedic services. One of the problems preventing clinics and hospitals from providing spine fusion services is the enormous strain on hospitals to offer COVID-19 patients.

Market Summary:

  • Product Type: We have covered Cervical Device, Thoracolumbar Device, Interbody Device an Biologics as product type.
  • Surgery Type: In our report we have studied, Open Surgery, Minimally Invasive
  • Disease Indicator Type: We have studied, Degenerative Disc Disease, Complex Deformity, Traumas & Fractures and Other
  • End-Users: Hospitals, Specialty Clinics and Ambulatory Surgical are the end-users covered in our report
  • Regions: In our report we have covered, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa
  • Company Analysis: The key players covered are Alphatec Holdings, Inc., B. Braun Group, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, Orthofix Medical Inc, Stryker, Zimmer Biomet Holdings)

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Medical Adhesives Market Size is expected to expand at a CAGR of 7.9% during 2021-2027

According to Renub Research report titled “Medical Adhesives Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the Medical Adhesives Market to reach USD 15.30 Billion by 2027. In the assembly of medical devices, medical adhesives comprise an integral part of healthcare delivery and are used by almost every medical specialty in all care settings. Medical adhesives are biocompatible, and their features of not irritating, sensitizing, or cytotoxic have expanded their use in medical equipment. Medical adhesives are majorly utilized in the medical industry to close up a patch or dress the skin wounds, fix medical devices such as tape, etc. It is utilized for bone and enamel reconstruction during surgeries. Various products are involved in medical adhesives, such as dressing, electrodes, patches tapes, and ostomy supplies.

Worldwide Medical Adhesives Market Size was US$ 9.70 Billion in 2021

Nonetheless, the population in developed countries such as the U.S., Germany, and Japan is aging rapidly. As per the United States Census Board, people above 65 years would account for 20% of the total population by 2030. According to the (UNU) United Nations University, one million people reach 60 years of age every month globally. The increasing geriatric population is the factor that increases medical adhesives demand, which in turn anticipated driving the development of the global market in the next few years. Further, the demand for silicone-based medical adhesives is caused by their ability to adhesion silicon and other difficult-to adhere substrates. In addition, silicone is characterized by extreme weather resistance and has more extended durability than acrylics.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=medical-adhesives-market-p.php

Dental application is the Fastest-growing Segment of Medical Adhesives Industry

In terms of application, the global medical adhesives market is categorized into medical device & equipment, internal, external, dental, and others. Dental adhesives deliver retention to composite fillings or composite cement. These adhesives find use in pit & fissure sealants and dental repair applications. Products in dental applications include Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives.

Apart from this, medical devices & equipment are utilized for hearing-aid molding, polycarbonate component assembly (e.g., heat exchangers, blood oxygenators, and surgical pumps) anesthesia-mask bonding, needle assembly, bonding of other medical devices. The product’s substrate versatility, thermal solid & chemical resistance, low shrinkage, high gap filling, high peel, and rapid cure are the significant factors driving their growth in medical devices & equipment.

North America to Lead Global Medical Adhesives Industry

In North America, increased patient awareness levels regarding wound infections and diseases and the rapidly growing senior population in this region, especially in the U.S, are the significant factors contributing to market growth. The evolution of the market player’s focus towards developed wound dressings analogized to the traditional staple and suture methods is the major trend witnessed in this region.

Notwithstanding, the Asia Pacific is the fastest-growing medical adhesive market. The Asia-Pacific medical adhesive market is predicted to expand due to the growing population, driving up the need for better medical facilities and preferring adhesive medical demand. The consistent increase in government spending on the healthcare sector and the updating of healthcare infrastructure are market expansions in this area.

COVID-19 Impact on Medical Adhesive

The pandemic had ramifications for ways of working of various surgical procedures. There are stringent guidelines specific to each specialty that must be implemented and followed for surgeons to continue providing adequate care and safety to their patients during the COVID-19 pandemic. The volume of surgeries has significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries, impacting the procurement of the medical adhesives market.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/medical-adhesives-market-p.php

Key Market Players

Numerous big and small players characterize the global medical adhesives market. The major market players include Avery Dennison Corporation, Ashland Global Holdings Inc., H.B. Fuller Company, Henkel AG & Co. KGaA, The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Dupoint De Nemours, Inc and Wacker Chemie AG.

Market Summary:

Product – We have covered Market breakup by 2 viewpoints by product (Synthetic & Semi-Synthetic Adhesives (Acrylic, Polyurethane, Epoxy, Silicone, and Others) and Natural or Biological Adhesive (Fibrin, Collagen, Albumin, and Others)

Application – Our Report covers by Application in the 5 viewpoints (Dental (Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives), Internal (Bone, Cranial, Pulmonary and Abdominal), External (Tissue Bonding Agents and Prosthesis Bonding Agents), Medical Device & Equipment and Others)

Technology – Global Medical Adhesives Market have been covered by technology from 5 viewpoints (Water based, Solvent based, Hot melt, Reactive & Others)

Region – This Report covers Global Medical Adhesives Market breakup by 4 Region (North America, Europe, Asia – Pacific, Central & South America, and Middle East)

All the key players have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) H.B. Fuller Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Ashland Global Holdings Inc., The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Wacker Chemie AG, and Dupoint De Nemours, Inc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

United States Endoscopy Devices Market is expected to grow at a CAGR of 7.19% from 2021 to 2027

According to the latest report by Renub Research, “United States Endoscopy Devices Market, Size, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the United States Endoscopy Devices Market Size is projected to reach US$ 27.9 Billion by 2027. Endoscopy devices are thin and long tubes inserted inside the body via mouth or incision to examine the interior of the bladder, stomach, ears, nose, esophagus, colon, throat, heart, joints, urinary tract, and abdomen. These tubes have a light source attached and a camera, which help healthcare professionals to perform laparoscopic and biopsies and arthroscopy surgeries. They are available in various lengths and flexibilities depending on diagnostic organs.

United States Endoscopy Devices Market to Grow with a CAGR of 7.19% from 2021 to 2027

United States Endoscopy Devices Market Size was US$ 18.8 Billion in 2021

The change in the trend of adoption from traditional open surgeries to minimally invasive techniques by healthcare professionals and patients is one of the primary factors growing the endoscopy devices market in the United States. Other factors promoting growth include the rising prevalence of chronic conditions, the increasing geriatric population, and technological advancements in endoscopy devices.

Moreover, the increasing number of neurological disorders and the rising adoption of minimally invasive surgeries attributed to the United States endoscopic devices market growth. As per ONP hospitals statistics, the United States contributes to 32% of the number, i.e., around 4,800,000 laparoscopic procedures are performed every year. This implies that endoscopic procedures are performed widely in the country.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-states-endoscopy-devices-market-p.php

Endoscopy Visualization Components product dominates the United States Endoscopy Devices Market

Depending on the product, the global endoscopy devices market is divided into Operative Devices, Endoscopy Visualization Components, Endoscopy Visualization Systems, and Endoscopes. The endoscopy visualization components register a significant dominance in the United States endoscopy devices industry. This is attributable to benefits provided by high-definition visualization systems for treating and diagnosing complex health conditions such as cancer, urinary disorders, GI disorders, and lung disorders and increasing preference of healthcare professionals towards utilizing endoscopy visualization systems for better diagnosis and treatment.

In United States G.I. Tumors accounts for the Second Highest Cause of cancer-related Deaths

In the United States, endoscopy sub-products like robot-assisted endoscopes, capsule endoscopes, and rigid endoscopes are widely used in various medical specialties applications, such as gastroenterology, urology, gynecology, pulmonology ENT, and others. The increasing burden of G.I. disorders, coupled with the growing geriatric population, is propelling the demand for Gastroenterology Endoscopy. G.I. tumors are the second most extensive cause of cancer-related deaths in the United States. Thus, an upsurge in endoscopic procedures for the early diagnosis of G.I. cancers offers considerable revenue opportunities.

Bariatric Surgery Drives the Capsule Endoscopy Market Growth

Although, sub-product Capsule endoscopy is widely used to detect minor bowel damage, Crohn’s disease, obscure intestinal bleeding, etc., in the United States. Capsule endoscopy has significant benefits for patients with small bowel disease for whom the proper diagnosis is not available. In addition, the capsule endoscope is on-demand due to its cost-effectiveness. Moreover, many surgical procedures using endoscopic procedures such as bariatric surgery boost the Capsule endoscopy market growth in the United States.

Besides, the market comprises both hospitals and ambulatory surgery centers/clinics by end-users. Nevertheless, in the United States, hospitals have emerged as the most primary health system. Thus, the number of endoscopic surgeries done at hospitals is relatively more than the other health systems, such as specialty clinics or Ambulatory Surgical Centers (ASCs).

COVID- 19 Impact on the United States Endoscopy Devices Industry:

COVID-19 is an incomparable global public health emergency that has affected the United States in almost every industry, including the endoscopy device industry. The primary cause for the decline in endoscopy procedures during the COVID-19 pandemic was decreased patient volume in hospitals due to delaying guidelines for safety reasons and rescheduling. Moreover, these delays happened after careful review of patient history, and healthcare providers rescheduled endoscopic procedures to minimize the chance of exposure to COVID-19 during hospital visits.

Competitive Landscape:

The United States endoscopy devices industry is highly competitive, and prominent players have adopted various strategies to increase their endoscopy devices market share. These include product launch, product development, product approval, and acquisition. Major US endoscopy devices market players include Boston Scientific Corporation, Medtronic Plc, Johnson and Johnson, Stryker, and Conmed.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-endoscopy-devices-market-p.php

Market Summary:

  • Product – We have covered United States Endoscopy Device Market breakup by 4 viewpoints by-product (Operative Devices, Endoscopy Visualization Components, Endoscopy Visualization Systems and Endoscopes)
  • Sub-Product – Renub Research Report covers by Sub-Product in the 5 viewpoints (Rigid Endoscopes, Robot Assisted Endoscopes, Disposable Endoscopes, Capsule Endoscopes and Flexible Endoscopes)
  • Application – Our Report has covered United States Endoscopy Device Market breakup by 6 Application (Gastroenterology, ENT Surgery, Gynecology, Neurology, Urology and Other Applications)
  • End Users – This Report covers by End Users in the 3 viewpoints (Hospitals, Ambulatory Surgery Centers/Clinics and Other End Uses)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Boston Scientific Corporation, Medtronic Plc, Johnson and Johnson, Stryker and Conmed.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Worldwide Defibrillators Industry will grow at a CAGR of 5.76% during 2021-2027

The latest report by Renub Researh, titled “Defibrillators Market Size, Share, Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis”  the Global Defibrillators Market Size was valued at US$ 12.87 Billion in 2021. The World Health Organization states that cardiovascular deaths are the most common cause of all registered deaths worldwide. In addition, economic development rates and industrialization have significantly added to the number of deaths due to sudden cardiac arrest. Further, sudden cardiac arrests are accompanied by immediate resuscitation, a combination of chest compressions, and assisted ventilation. Hence, defibrillation is an effective treatment option accepted globally to treat cardiac arrest due to ventricular fibrillation. A defibrillator incorporates the concept of defibrillation, which is an electronic device, which is prominently used to treat arrhythmia and sudden cardiac arrest.

Global Defibrillators Market will be US$ 18.01 Billion by 2027

Worldwide Defibrillators Industry will grow at a CAGR of 5.76% during 2021-2027

SCA is a sudden and unanticipated pulseless situation caused by the cessation of cardiac mechanical activity. SCA is a foremost cause of death among adults, usually above the age of 40. SCA is one of the prominent driving factors for evolving the defibrillators industry. Moreover, the rising incidence of atherosclerosis, diabetes, strokes, hypertension, and others due to lifestyle habits such as unhealthy dietary habits, lack of physical activity, and smoking, among others, is the ultimate cause of CHF. Moreover, the rising geriatric population base is anticipated to fuel CHF prevalence, increasing defibrillator market growth.

External Defibrillator Is Expected to Grow at A Great Pace During The Forecast Period:

By Product type, we have categorized the global defibrillator market into the Implantable Cardioverter Defibrillator and External Defibrillator market. The demand for External Defibrillator will grow significantly during the forecast period. External defibrillators are life-saving devices that deliver a defibrillating shock to diagnose and restore heart rhythms in an unexpected cardiac arrest. Apart from that, the market of Implantable Cardioverter Defibrillator will also flourish during 2021-2027.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=defibrillator-market-forecast-p.php

AED Is the Most Preferred External Defibrillation System:

External defibrillators are life-saving medical devices used to deliver defibrillating shock through paddles or electrode pads to diagnose and restore life-threatening abnormal heart rhythms in the conditions of unexpected cardiac arrest. These devices can perform cardioversion, defibrillation, and pacing of the heart. External defibrillators are of three major types: manual external defibrillators, AEDs and WCDs. AEDs are used in most cases among SCA patients due to abundant opportunities observed and ease in use, thereby bagging a significant market share in the global defibrillators market.

The North American Region Hold Considerable Share:

We have studied the regional realms of the global defibrillators industry in North America, Latin America, Europe, Asia Pacific and the Middle East and Africa region. Higher Adoption of Defibrillator Installations and Implants Enables Market to Hold Considerable Share in North America. North America is envisioned to dominate the market throughout the forecast period. Growing installations of external defibrillators in hospitals and public places such as schools, hotels, streets, railway stations, and others to prevent fatalities from sudden cardiac arrest are prominently responsible for holding a higher defibrillator market share in North America.

Moreover, the incremental shift of preference towards subcutaneous ICD due to growing patient awareness is projected to augment the growth of ICD in North America. Europe is anticipated to be the second most prominent region in terms of market share by 2027. In addition, the market is rising at a faster pace in emerging countries of the Asia Pacific region, owing to increasing adoption and rapidly developing healthcare infrastructure.

Key Market Players:

Medtronic, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, and Asahi Kasei Corporation are amongst a leading player in the defibrillator market owing to their diverse product offering in the implantable defibrillator segment, efficient customer reach, and vital after-sales service. Our report also covers operate in the defibrillator industry.

For instance, in April 2020 – Philips, a health technology company, announced that it’s Emergency Care and Resuscitation (ECR) business is recommencing the manufacturing and shipping of external defibrillators for the US. The company declared that the US Food and Drug Administration (FDA) had lifted the limitations imposed on the manufacturing and allocation of defibrillators in the US.

COVID-19 Impact on Global Defibrillators Market:

All over the world, COVID-19 is known to affect the cardiovascular system, resulting in myocardial injury, arrhythmias, intravascular thrombosis, and sudden cardiac death. Further, initial reports have also recommended a temporary association between COVID-19 activity and cardiac arrests in the community and in hospital settings. Remarkably, life-threatening arrhythmias have been variably reported among patients hospitalized for COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Hence, defibrillator shock episodes have risen during the higher COVID-19 activity boosting the market for Global Defibrillators Market.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/defibrillator-market-forecast-p.php

Market Summary:

  • Product Type: We have covered Implantable Cardioverter Defibrillator and External Defibrillator.
  • Implantable Cardioverter Defibrillator: We have studied Transvenous Implantable Cardioverter Defibrillators (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) and others in our report.
  • Transvenous Implantable Cardioverter Defibrillators: We have covered Single-Chamber Implantable Cardioverter Defibrillators, Dual-Chamber Implantable Cardioverter Defibrillators, Biventricular Implantable Cardioverter Defibrillators /Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
  • External Defibrillator: In our report we have studied Automated External Defibrillators, Advanced Life Support Defibrillators, Wearable Cardioverter Defibrillators
  • End Users: Hospital, Prehospital, Public Access Market, Alternate Care Market, Home Healthcare are the end users in the market.
  • Regions: We have studied the regional realms such as North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
  • Company: The key players studied in our report include Medtronic Plc, Boston Scientific Corporation, Philips Healthcare, Nihon Kohden Corporation, Asahi Kasei Corporation.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global LiDAR Market to Grow with Double-digit CAGR of 15.75% from 2021-2027

The latest report by Renub Research, titled “LiDAR Market Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the LiDAR Market will be USD 3.92 Billion by 2027. LiDAR, which determines light detection and ranging, is a popular remote sensing system used to measure the exact range of an object on Earth surface, even though it was primarily applied in the 1960s during laser scanners were mounted to aeroplanes. LiDAR is one of the numerous promising sensor-based technologies is reflected in a combination of laser scanning and 3D scanning thus; it can also be described as 3D laser scanning. Prominently LiDAR technology is categorized into three type’s Aerial, Terrestrial, Mobile and Short Range.

Global LiDAR Market to Grow at CAGR of 15.75% from 2021-2027


Moreover, the rising adoption of LiDAR systems in UAVs, the emergence of 4D LiDAR, and easing of laws related to the use of commercial drones in different forms are among the factors of the global LiDAR market. The main factor driving the LiDAR industry’s growth is LiDAR systems’ improved automated processing ability in model resolution and data processing capabilities over other technologies.


Inertial Navigation System and LASER components Demand are Rising Worldwide

Besides, the primary components of the LiDAR system are LASER, Inertial Navigation System, Camera, GPS GNSS Receiver, MEMS (Micro Electro Mechanical Systems. LiDAR uses a pulsed laser component to calculate an object’s variable distances from the earth surface. These light pulses put together with the information collected by the airborne system generate accurate 3D details on the earth surface and the target object. Notwithstanding, inertial technology has been leveraged in a range of high-precision LiDAR implementations on a range of platforms including vehicle-based, and both operated and unmanned aerial systems.


LiDAR technology is used in many applications, such as corridor mapping, seismology, exploration & detection and others. Light detection and ranging (LiDAR) corridor mapping is becoming an established system of creating detailed geo-referenced spatial information of a surrounding and its characteristics. LiDAR -based corridor mapping solutions are agile and are utilized on a moving vehicle or stationary.


Worldwide LiDAR Market Size was USD 1.63 Billion in 2021

Based on end-users verticals, the global LiDAR industry is segmented into Defense & Aerospace, Civil Engineering, Archaeology, Forestry & Agriculture, Mining and Transportation. LiDAR is widely used in civil engineering, find crucial importance in the LiDAR technology for the aerial and terrestrial scanning to provide valuable insights as to the existing architecture or details regarding the security of the inclinations and other factors, which could play a vital role in the growth of the plans for construction and other. In the agriculture industry, LiDAR is used for surveying fields with drones and automated tractor steering solutions. And Amazon forest uses LiDAR cameras and photography to create digital maps of neighborhoods, which it is also working to utilize for its delivery robots.


North America is the Leader in the LiDAR Technology Industry

Worldwide, North America is one of the significant technology developers, owing to increasing investments in accelerating innovations in the LiDAR landscape. Many industries in North America adopt these types of LiDAR systems, especially for application in the automotive industry. LiDAR is primarily used for the (ADAS) advanced driver assistance systems in automobiles for the driver’s convenience, with a human-machine interface for safe guidance and smooth operation.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=lidar-market-p.php 


Additionally, as per the US Department of Transportation Data, 51% of freight miles are available in nations approved commercial vehicle platooning. LiDAR technology is used in (UAS) Unmanned Aircraft Systems. The US army and civil governments are increasing their operations for UAS, raising the demand for LiDAR in the US.


Moreover, countries such as India, Malaysia and China are anticipated to increase speeding in drone technology for defense in the forecast period. Asian Companies are being adopted by a growing number of industries, especially for application in engineering, construction, environment, and exploration, proving the effectiveness and, therefore, demand for LiDAR  technology.


COVID-19 Impact on Global LiDAR Industry

The COVID-19 pandemic has affected the companies present in the LiDAR ecosystem. It has affected both end-users and manufacturers of LiDAR globally. Among applications, the LiDAR industry in gas and mining purposes and oil for exploration is hit the most by COVID-19. The commanded lockdowns over the world have impacted the economies of the countries globally.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/lidar-market-p.php 


Major vendors in the LiDAR  market, such as Faro Technologies Inc, Hexagon AB, Vaisala Oyj Sick A, and Teledyne Technologies Inc. These various companies prevalent in the market are challenged to provide innovative offerings changing technologies, which help consumers, business practices, and security needs.


Market Summary

  • Type – We have covered by type market breakup by 4 viewpoints (Terrestrial, Aerial, Mobile and Short Range)
  • Components – Renub Research Report covers by Components market breakup by 5 viewpoints (LASER, Inertial Navigation System, Camera, GPS GNSS Receiver, MEMS (Micro Electro Mechanical Systems)
  • Application – Our Report covers by application market breakup by 4 viewpoints (Corridor Mapping, Seismology, Exploration & Detection and others)
  • End-User – This Report covers by End-Users market breakup by 4 viewpoints (Defense & Aerospace, Civil Engineering, Archaeology, Forestry & Agriculture, Mining and Transportation)
  • Region – Report covers by Region market breakup by 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
  • All the key players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue) Faro Technologies Inc, Hexagon AB, Vaisala Oyj Sick A, and Teledyne Technologies Inc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch